iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$101.26 Million

₩148.27 Billion KRW

Market Cap Rank

#18967 Global

#732 in Korea

Share Price

₩4690.00

Change (1 day)

+3.08%

52-Week Range

₩2915.00 - ₩6650.00

All Time High

₩46250.00

iNtRON Biotechnology Inc - Asset Resilience Ratio

Latest as of September 2025: 10.90%

iNtRON Biotechnology Inc (048530) has an Asset Resilience Ratio of 10.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩8.58 Billion

Cash + Short-term Investments

Total Assets

₩78.70 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how iNtRON Biotechnology Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down iNtRON Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩8.58 Billion	10.9%
Total Liquid Assets	₩8.58 Billion	10.90%

Asset Resilience Insights

Moderate Liquidity: iNtRON Biotechnology Inc has 10.90% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.